. Author manuscript; available in PMC: 2017 Nov 7.

Published in final edited form as: Am J Cardiol. 2017 Jul 24;120(8):1293–1297. doi: 10.1016/j.amjcard.2017.07.012

Table 4.

Adjusted odds for outcomes (secondary analysis). Statistical significance for categorical variables tested using Pearson test and Deuchler-Wilcoxon procedure for continuous variables

Outcome	β-blocker
Outcome	Adjusted OR (95% CI)^*
Delirium incidence	0.96 (0.79 to 1.17)
Delirium duration	0.94 (0.77 to 1.14)
Kidney Disease: Improving Global Outcome
Stage 1	1.11 (0.89 to 1.38)
Stage 2	1.27 (0.71 to 2.27)
Stage 3	0.70 (0.30 to 1.64)
Atrial fibrillation	1.16 (0.98 to 1.38)
Mortality
90 days	1.04 (0.59 to 1.86)
1-year	1.01 (0.66 to 1.55)
Length of stay (Δdays)	0.08 (−0.15 to 0.31)
Stroke	1.02 (0.58 to 1.80)

CI = confidence interval; OR = odds ratio.

p < 0.05.